Sécurisation de l’administration des médicaments en anesthésie par le déploiement des connecteurs NRFIT : expérience d’un hôpital universitaire français
Annales Pharmaceutiques Françaises · 2026-05
DOI: 10.1016/j.pharma.2026.05.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2026-05. Verfasst von Eva Garbil und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unité des dispositifs médicaux stériles, service pharmaceutique, hôpital Édouard-Herriot (HCL), 24, rue Trarieux, 69003 Lyon, France. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES This study reports the experience of a French university hospital transitioning from Luer connectors to the secure NRFIT standard for neuraxial applications, with the aim to prevent serious drug administration errors. The objective was to describe the project approach, to share feedback, and to provide a preliminary evaluation of the economic impact. METHODS A multidisciplinary project group involving pharmacy and anesthesiology-critical care departments was established. The process included an exhaustive inventory and rationalisation of Luer medical devices (MD), followed by identification and validation of equivalent NRFIT devices through technical reviews and bench testing. The deployment was carefully planned using a Gantt chart, supported by an internal communication and training plan, and included a temporary three-month buffer stock of NRFIT devices. A post-transition analysis assessed the costs of withdrawn Luer stock and compared procurement costs between NRFIT and Luer systems. RESULTS Of a total of 65 preexisting references of MDs, 44 were retained then converted to a NRFIT equivalent reference during a two-phase rollout in July and August 2025, driven by supplier availability. Multidisciplinary coordination and detailed planning were key success factors. Challenges included supply delays and the management of patients transferred from other hospitals equipped with Luer devices, requiring specific protocols. The transition resulted in a net loss of €7,873 from withdrawn Luer stock and a provisional annual cost increase of €11,224. CONCLUSIONS The transition to NRFIT connectors was feasible and safe despite organisational and financial constraints. Strong multidisciplinary leadership, careful planning, effective communication, and training were essential. Wider adoption of NRFIT devices across hospitals may help reduce additional purchasing costs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unité des dispositifs médicaux stériles, service pharmaceutique, hôpital Édouard-Herriot (HCL), 24, rue Trarieux, 69003 Lyon, France.
- Département d'anesthésie-réanimation, hôpital Édouard-Herriot (HCL), 5, place d'Arsonval, 69003 Lyon, France.
- Unité des dispositifs médicaux stériles, service pharmaceutique, hôpital Édouard-Herriot (HCL), 24, rue Trarieux, 69003 Lyon, France. Electronic address: xavier.armoiry@chu-lyon.fr.
Zitieren
APA
Garbil, E., Drouin-Bonnet, A., Kerhoas, A., Gasnier, F., & Armoiry, X. (2026). Sécurisation de l’administration des médicaments en anesthésie par le déploiement des connecteurs NRFIT : expérience d’un hôpital universitaire français. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.05.004
Vancouver
Garbil E, Drouin-Bonnet A, Kerhoas A, Gasnier F, Armoiry X. Sécurisation de l’administration des médicaments en anesthésie par le déploiement des connecteurs NRFIT : expérience d’un hôpital universitaire français. Annales Pharmaceutiques Françaises. 2026. doi:10.1016/j.pharma.2026.05.004
BibTeX
@article{Garbil2026,
author = {Garbil, Eva and Drouin-Bonnet, Arthur and Kerhoas, Anne and Gasnier, Fabrice and Armoiry, Xavier},
title = {Sécurisation de l’administration des médicaments en anesthésie par le déploiement des connecteurs NRFIT : expérience d’un hôpital universitaire français},
journal = {Annales Pharmaceutiques Françaises},
year = {2026},
doi = {10.1016/j.pharma.2026.05.004}
}
EUVIMED